Savella
NDC Package 50436-9993-2
Package Information
Savella is milnacipran is used to treat pain caused by a condition called fibromyalgia that affects the muscles, tendons, ligaments, and supporting tissues. Marketed by Unit Dose Services, this product is identified by NDC 50436-9993 and is authorized under FDA application NDA022256.
Identification & Billing
- RxCUI: 833147 - milnacipran HCl 25 MG Oral Tablet
- RxCUI: 833147 - milnacipran hydrochloride 25 MG Oral Tablet
- RxCUI: 833149 - Savella 25 MG Oral Tablet
- RxCUI: 833149 - milnacipran hydrochloride 25 MG Oral Tablet [Savella]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 50436 - Unit Dose Services
- 50436-9993 - Savella
- 50436-9993-2 - 60 TABLET, FILM COATED in 1 BOTTLE
- 50436-9993 - Savella
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50436-9993-2 identifies a specific commercial package of 60 tablet, film coated in 1 bottle of Savella, labeled by Unit Dose Services. This product is billed for "EA" each discreet unit and contains an estimated amount of 60 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Unit Dose Services on April 17, 2009. The current certification is valid through December 31, 2020.
What are the primary indications for this medication?
Milnacipran is used to treat pain caused by a condition called fibromyalgia that affects the muscles, tendons, ligaments, and supporting tissues. This medication is a serotonin-norepinephrine reuptake inhibitor (SNRI) that works by helping to restore the balance of certain natural substances in the brain (neurotransmitters).
How is this Unit Dose Services product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50436999302. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.